| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | United States | 3 | |
| #4 | Australia | 2 | |
| #5 | New Zealand | 2 | |
| #6 | Brazil | 1 | |
| #7 | Canada | 1 | |
| #8 | China | 1 | |
| #9 | Israel | 1 | |
| #10 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology | |
| #4 | IT methods for management |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Analysing materials | |
| #3 | Measuring microorganism processes | |
| #4 | Medical preparations | |
| #5 | Data processing systems | |
| #6 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bacus Sarah S | 18 |
| #2 | Bacus Sarah | 3 |
| #3 | Hill Jason E | 2 |
| #4 | Moran Diarmuid | 2 |
| #5 | Kochupurakkal Bose S | 1 |
| #6 | Yarden Yosef | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2011109625A1 | Methods for determining responsiveness to a drug based upon determination of ras mutation and/or ras amplification | |
| EP2438443A1 | Methods for the detection and quantitation of the p95 component of her2/neu (erbb2) | |
| EP2438186A1 | Methods for the detection and quantitation of pten | |
| CA2643846A1 | Methods for predicting cellular toxicity upon treatment with tyrosine kinase inhibitors | |
| AU2007213709A1 | Bivalent ErbB ligand binding molecules and methods for their preparation and use |